61 related articles for article (PubMed ID: 7841544)
1. Reversal of multiple drug resistance by tolyporphin, a novel cyanobacterial natural product.
Smith CD; Prinsep MR; Caplan FR; Moore RE; Patterson GM
Oncol Res; 1994; 6(4-5):211-8. PubMed ID: 7841544
[TBL] [Abstract][Full Text] [Related]
2. Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance.
Smith CD; Carmeli S; Moore RE; Patterson GM
Cancer Res; 1993 Mar; 53(6):1343-7. PubMed ID: 8095179
[TBL] [Abstract][Full Text] [Related]
3. Differential interactions of cytochalasins with P-glycoprotein.
Zilfou JT; Smith CD
Oncol Res; 1995; 7(9):435-43. PubMed ID: 8835287
[TBL] [Abstract][Full Text] [Related]
4. Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistance.
Smith CD; Zilfou JT; Stratmann K; Patterson GM; Moore RE
Mol Pharmacol; 1995 Feb; 47(2):241-7. PubMed ID: 7870031
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
Politi PM; Arnold ST; Felsted RL; Sinha BK
Mol Pharmacol; 1990 Jun; 37(6):790-6. PubMed ID: 1972771
[TBL] [Abstract][Full Text] [Related]
6. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
7. Tolyporphins J and K, two further porphinoid metabolites from the cyanobacterium Tolypothrix nodosa.
Prinsep MR; Patterson GM; Larsen LK; Smith CD
J Nat Prod; 1998 Sep; 61(9):1133-6. PubMed ID: 9748382
[TBL] [Abstract][Full Text] [Related]
8. Reversal of multidrug resistance by two novel indole derivatives.
Kadam S; Maus M; Poddig J; Schmidt S; Rasmussen R; Novosad E; Plattner J; McAlpine J
Cancer Res; 1992 Sep; 52(17):4735-40. PubMed ID: 1355008
[TBL] [Abstract][Full Text] [Related]
9. The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells.
Traunecker HC; Stevens MC; Kerr DJ; Ferry DR
Br J Cancer; 1999 Nov; 81(6):942-51. PubMed ID: 10576649
[TBL] [Abstract][Full Text] [Related]
10. B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.
Borchers C; Ulrich WR; Klemm K; Ise W; Gekeler V; Haas S; Schödl A; Conrad J; Przybylski M; Boer R
Mol Pharmacol; 1995 Jul; 48(1):21-9. PubMed ID: 7623771
[TBL] [Abstract][Full Text] [Related]
11. alpha-(3,4-dimethyoxyphenyl)-3,4-dihydro-6,7-dimethoxy-alpha- [(4-methylphenyl)thio]-2(1H)-isoquinolineheptanenitrile (CL 329,753): a novel chemosensitizing agent for P-glycoprotein-mediated resistance with improved biological properties compared with verapamil and cyclosporine A.
Greenberger LM; Collins KI; Annable T; Boni JP; May MK; Lai FM; Kramer R; Citeralla RV; Hallett WA; Powell D
Oncol Res; 1996; 8(5):207-18. PubMed ID: 8884813
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
13. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.
Dantzig AH; Shepard RL; Cao J; Law KL; Ehlhardt WJ; Baughman TM; Bumol TF; Starling JJ
Cancer Res; 1996 Sep; 56(18):4171-9. PubMed ID: 8797588
[TBL] [Abstract][Full Text] [Related]
14. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells.
Aftab DT; Yang JM; Hait WN
Oncol Res; 1994; 6(2):59-70. PubMed ID: 7949466
[TBL] [Abstract][Full Text] [Related]
15. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Kumar A; Soprano DR; Parekh HK
Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
[TBL] [Abstract][Full Text] [Related]
16. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
Chou TC; Guan Y; Soenen DR; Danishefsky SJ; Boger DL
Cancer Chemother Pharmacol; 2005 Oct; 56(4):379-90. PubMed ID: 15875185
[TBL] [Abstract][Full Text] [Related]
17. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
[TBL] [Abstract][Full Text] [Related]
18. Selective modulation of P-glycoprotein-mediated drug resistance.
Bebawy M; Morris MB; Roufogalis BD
Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of activities of anti-tumor drugs by dipyridamole against multidrug-resistant human hepatoma PLC/PRF/5 cells.
Tatsuta T; Shimizu K; Nishimura T; Suzuki H
Anticancer Drug Des; 1991 Jul; 6(3):179-88. PubMed ID: 1678605
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
Peer D; Dekel Y; Melikhov D; Margalit R
Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
